Tagmokitug
Gecertificeerd

Tagmokitug

Catalog #: HY-P991061-01
Maat: 1 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

Description

Tagmokitug (CHS-114) is a fully human IgG1 antibody that targets CCR8. Tagmokitug has the potential for the study of head and neck squamous cell carcinoma (HNSCC). The isotype control for Tagmokitug can refer to Human IgG1 lambda2, Isotype Control.

CAS Number

3024486-14-1

Product Name Alternative

CHS-114; SRF-114

UNSPSC

12352203

Target

CCR

Related Pathways

GPCR/G Protein; Immunology/Inflammation

Applications

Cancer-programmed cell death

Field of Research

Cancer

Smiles

[Tagmokitug]

References & Citations

[1]N. Rajasekaran, et al. CHS-114: A Cytolytic Anti-CCR8 Antibody that Depletes Tumor-infiltrating Regulatory T Cells as a Treatment for Head and Neck Squamous Cell Carcinoma. Volume 118, Issue 5e89April 01, 2024.

Shipping Conditions

Room temperature

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-P991061/

Scientific Category

Inhibitory Antibodies

Clinical Information

Phase 1

Beschrijving

Tagmokitug (CHS-114) is a fully human IgG1 antibody that targets CCR8. Tagmokitug has the potential for the study of head and neck squamous cell carcinoma (HNSC

Specificaties

ProductnaamTagmokitug
Categorie
Beschikbare grootte1 mg
CatalogusnummerHY-P991061-01